Mark Sheptoff Financial Planning, LLC Century Therapeutics, Inc. Transaction History
Mark Sheptoff Financial Planning, LLC
- $180 Million
- Q2 2025
A detailed history of Mark Sheptoff Financial Planning, LLC transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Mark Sheptoff Financial Planning, LLC holds 500 shares of IPSC stock, worth $295. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$295
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding IPSC
# of Institutions
64Shares Held
23.7MCall Options Held
33.4KPut Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$3.19 Million0.91% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$1.71 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.11MShares$1.24 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.02MShares$1.19 Million0.0% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA1.7MShares$1.01 Million0.28% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $34.7M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...